BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3283237)

  • 1. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
    Fukuoka Y; Hugli TE
    J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
    Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
    Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S; Ecker U; Hadding U; Bitter-Suermann D
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW
    J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma.
    Molinas FC; Wietzerbin J; Falcoff E
    J Immunol; 1987 Feb; 138(3):802-6. PubMed ID: 2949008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D
    Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets.
    Chen H; Marjan J; Cox AD; Devine DV
    J Immunol; 1994 Feb; 152(3):1332-8. PubMed ID: 8301135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of 125I-labelled C3a by cultured human endothelial cells.
    Denney JB; Johnson AR
    Immunology; 1979 Feb; 36(2):169-77. PubMed ID: 437829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
    Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
    Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.